DNA strand and cancer cell
Genetic research may boost success of immunotherapy

Cancer cells are sneaky. They are often able to hide from the body’s immune system, and sometimes they can even prevent an immune system attack from happening.

A smiling couple walking down a tree-lined dirt road
What does the future of cancer in Canada look like?

Dr Darren Brenner is a researcher at the University of Calgary in the Department of Cancer Epidemiology and Prevention Research. He is also one of the scientists leading the ComPARe project, a study funded by the Canadian Cancer Society (CCS) that is estimating current and future impact of cancer on Canadians’ health. He spoke to CCS about the project and the importance of cancer prevention research.

Your trusted source for the most up-to-date cancer statistics in Canada

For more than 30 years, the Canadian Cancer Statistics publication has provided comprehensive, up-to-date cancer statistics for Canada. Developed collaboratively by the Canadian Cancer Society, Public Health Agency of Canada, Statistics Canada and provincial and territorial cancer registries, the 2017 edition was released on June 20.

zoomed-in view of the body’s blood vessels
Detecting cancer early in the blood

Watch video

animation of a CAR-T cell interacting with a target protein on a cancer cell
How CAR-T cells work to fight cancer

Watch video

Cancer Dialogues video – ARCC
Making decisions about funding cancer drugs in Canada

Watch video

Personalized medicine: Transforming cancer treatment

Personalized medicine uses information about a person to prevent, diagnose and treat disease. It helps doctors choose treatments based on a person’s genes or other features of the type of cancer the person has.

Bacteria meets cancer: Why some chemotherapies fail

Researchers from the Weizmann Institute of Science and Harvard Medical School have discovered how certain bacteria can protect cancers from chemotherapy, and what this means for cancer drug development. Learn more in an article from The Atlantic.

Examining palliative and end-of-life care in Canadian cancer patients

Palliative and end-of-life care have been linked to some benefits for cancer patients, yet they are not well integrated into the cancer treatment process. A recent report by the Canadian Partnership Against Cancer addresses these issues and offers a new model for integrating palliative care. Learn more in an article from the Canadian Partnership Against Cancer.

Lowering oxygen raises potential of cancer-killing T cells

Immunotherapy, a method of killing cancer using the body’s own immune system, is effective for some, but not all patients. A new study reported immune cells starved of oxygen were more effective at killing cancer, suggesting that oxygen starvation could improve immunotherapy. Learn more in an article from the Weizmann Institute of Science.

New breast cancer screening method heading for clinical trial

Women are often anxious or worried about their test results after a mammogram. A new screening tool being developed by a Lakehead University researcher may be quicker and more effective at detecting breast cancer. This technology should be ready for clinical testing in 2018. Learn more in an article from CBC News.

New treatment for non-Hodgkin lymphoma approved by FDA

Patients with follicular lymphoma often relapse after treatment, creating an urgent need for more effective and targeted therapies. The FDA recently approved a new drug to treat follicular lymphoma in the U.S. Learn more in an article from the American Association for Cancer Research blog.